185 related articles for article (PubMed ID: 22848177)
1. Enhanced oral bioavailability of docetaxel by lecithin nanoparticles: preparation, in vitro, and in vivo evaluation.
Hu K; Cao S; Hu F; Feng J
Int J Nanomedicine; 2012; 7():3537-45. PubMed ID: 22848177
[TBL] [Abstract][Full Text] [Related]
2. Enhanced oral delivery of docetaxel using thiolated chitosan nanoparticles: preparation, in vitro and in vivo studies.
Saremi S; Dinarvand R; Kebriaeezadeh A; Ostad SN; Atyabi F
Biomed Res Int; 2013; 2013():150478. PubMed ID: 23971023
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation in vitro and in vivo of docetaxel loaded mixed micelles for oral administration.
Dou J; Zhang H; Liu X; Zhang M; Zhai G
Colloids Surf B Biointerfaces; 2014 Feb; 114():20-7. PubMed ID: 24157590
[TBL] [Abstract][Full Text] [Related]
4. Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity.
Wang L; Liu Z; Liu D; Liu C; Juan Z; Zhang N
Int J Pharm; 2011 Jul; 413(1-2):194-201. PubMed ID: 21540085
[TBL] [Abstract][Full Text] [Related]
5. Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation.
Yin YM; Cui FD; Mu CF; Choi MK; Kim JS; Chung SJ; Shim CK; Kim DD
J Control Release; 2009 Dec; 140(2):86-94. PubMed ID: 19709639
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel.
Shi LL; Lu J; Cao Y; Liu JY; Zhang XX; Zhang H; Cui JH; Cao QR
Drug Dev Ind Pharm; 2017 May; 43(5):839-846. PubMed ID: 27487431
[TBL] [Abstract][Full Text] [Related]
7. Improved Bioavailability and Antitumor Effect of Docetaxel by TPGS Modified Proniosomes: In Vitro and In Vivo Evaluations.
Liu H; Tu L; Zhou Y; Dang Z; Wang L; Du J; Feng J; Hu K
Sci Rep; 2017 Mar; 7():43372. PubMed ID: 28266539
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of docetaxel-loaded lecithin-stabilized micellar drug delivery system (L
Su CY; Liu JJ; Ho YS; Huang YY; Chang VH; Liu DZ; Chen LC; Ho HO; Sheu MT
Eur J Pharm Biopharm; 2018 Feb; 123():9-19. PubMed ID: 29154834
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
10. Crafting Docetaxel-Loaded Albumin Nanoparticles Through a Novel Thermal-Driven Self-Assembly/Microfluidic Combination Technology: Formulation, Process Optimization, Stability, and Bioavailability.
Du J; Shi LL; Jiang WW; Liu XA; Wu XH; Huang XX; Huo MW; Shi LZ; Dong J; Jiang X; Huang R; Cao QR; Zhang W
Int J Nanomedicine; 2024; 19():5071-5094. PubMed ID: 38846644
[TBL] [Abstract][Full Text] [Related]
11. PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy.
Wang Y; Chen L; Tan L; Zhao Q; Luo F; Wei Y; Qian Z
Biomaterials; 2014 Aug; 35(25):6972-85. PubMed ID: 24836952
[TBL] [Abstract][Full Text] [Related]
12. Co-administration with cell penetrating peptide enhances the oral bioavailability of docetaxel-loaded nanoparticles.
Bu X; Zhu T; Ma Y; Shen Q
Drug Dev Ind Pharm; 2015 May; 41(5):764-71. PubMed ID: 24669977
[TBL] [Abstract][Full Text] [Related]
13. Sustained release docetaxel-incorporated lipid nanoparticles with improved pharmacokinetics for oral and parenteral administration.
Qureshi OS; Kim HS; Zeb A; Choi JS; Kim HS; Kwon JE; Kim MS; Kang JH; Ryou C; Park JS; Kim JK
J Microencapsul; 2017 May; 34(3):250-261. PubMed ID: 28557649
[TBL] [Abstract][Full Text] [Related]
14. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
15. Perspectives of nanoemulsion assisted oral delivery of docetaxel for improved chemotherapy of cancer.
Verma P; Meher JG; Asthana S; Pawar VK; Chaurasia M; Chourasia MK
Drug Deliv; 2016; 23(2):479-88. PubMed ID: 24901205
[TBL] [Abstract][Full Text] [Related]
16. Functionalized docetaxel-loaded lipid-based-nanosuspensions to enhance antitumor efficacy in vivo.
Pang X; Wang T; Jiang D; Mu W; Zhang B; Zhang N
Int J Nanomedicine; 2019; 14():2543-2555. PubMed ID: 31114190
[No Abstract] [Full Text] [Related]
17. Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorption.
Attili-Qadri S; Karra N; Nemirovski A; Schwob O; Talmon Y; Nassar T; Benita S
Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17498-503. PubMed ID: 24101508
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of lipid emulsions of docetaxel-linoleic acid conjugate in breast cancer.
Zhang T; Li M; Yang R; Zhang D; Guan J; Yu J; Yang B; Zhang H; Zhang S; Liu D; Wang Y
Int J Pharm; 2018 Jul; 546(1-2):61-69. PubMed ID: 29763687
[TBL] [Abstract][Full Text] [Related]
19. Ceramide lipid-based nanosuspension for enhanced delivery of docetaxel with synergistic antitumor efficiency.
Wang T; Feng L; Yang S; Liu Y; Zhang N
Drug Deliv; 2017 Nov; 24(1):800-810. PubMed ID: 28502199
[TBL] [Abstract][Full Text] [Related]
20. Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation.
Saremi S; Atyabi F; Akhlaghi SP; Ostad SN; Dinarvand R
Int J Nanomedicine; 2011 Jan; 6():119-28. PubMed ID: 21289989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
